Ethnopharmacological relevance: The investigated plant species are traditionally used by Venda people of South Africa, in the treatment of malaria and associated symptoms.
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Introduction
Despite the significant advances made in lessening the burden of malaria in recent years, the disease still remains a major public health problem affecting many people in tropical and subtropical regions (Murray et al., 2012) . This is especially the case in sub-Saharan Africa where 90% of the estimated annual global malaria deaths occur (World Health Organization, 2013) . Most of the conventional drugs are no longer effective due to the emergence of drug resistant strains. Additionally, some of the indispensable drugs that are still effective suffer from problems related to toxicity, prolonged treatment schedules, variable responses between strains, noncompliance by patients and inaccessibility to proper health facilities (Olasehinde et al., 2012) . These factors combined with the absence of effective vaccines highlight the need for new chemotherapeutic agents with novel modes of action that may alleviate the burden of malaria. In our search for novel antimalarial plant products (Prozesky et al., 2001; Tetyana et al., 2002; Adelekan et al., 2008) , twenty indigenous plant species used to treat malaria and/or malarial symptoms by Venda people, were evaluated for their antiplasmodial efficacy. We report here on the preliminary results of the study.
Materials and methods

Plant collection
An ethnobotanical survey and a chemotaxomic approach were followed to select and collect indigenous plant species used to treat malaria and its symptoms by Venda people. (Bandeira et al., 2001; Mabogo, 1990; Watt and Breyer-Brandwijk, 1962) resulting aqueous extracts were freeze-dried using a bench top manifold freeze dryer (Virtis). Dichloromethane and aqueous crude extracts were analysed independently.
In vitro antiplasmodial assay
In vitro activity of the acquired plant extracts (43) was determined following a Plasmodium falciparum as the test organism (Matile and Pink, 1990) . Plant extracts were dissolved in DMSO at 10 mg/ml and added to parasite cultures incubated in RPMI 1640 medium without hypoxanthine, supplemented with HEPES (5.94 g/l), NaHCO3 (2.1 g/l), neomycin (100 U/ml), AlbumaxR (5 g/l) and washed human red cells A+ at 2.5% haematocrit. Chloroquine (Sigma) was used as the standard drug.
Serial drug dilutions of eleven 3-fold dilution steps were prepared. The 96-well plates were incubated in a humidified atmosphere at 37 °C, 4% CO2, 3% O2 and 93% N2.
After 48 h 50 μl of [ 3 H]hypoxanthine was added to each well. Plates were incubated for a further 24 h and then harvested with a Betaplate™ cell harvester (Wallac). Red blood cells were transferred onto a glass fibre filters, washed and the dried filters were then inserted into a plastic foil and counted in a Betaplate™ liquid scintillation counter (Wallac). IC50 values were calculated from sigmoidal inhibition curves by linear regression using Microsoft Excel (Huber and Koella, 1993) .
Cytotoxicity assay
The antiproliferative activity of plant extracts was assessed on rat skeletal myoblasts L-6 cells (Ahmed et al., 1994) . Assays were performed in 96-well microtiter plates, each well containing 100 μl of RPMI 1640 medium supplemented with 1% L-glutamine (200mM), 10% fetal bovine serum and 4000 L-6 cells.
Podophyllotoxin was used as a control. Serial drug dilutions with a range of 100 to 0.002 μg/ml were conducted. After 70 hours of incubation the plates were inspected under an inverted microscope. 10μl of Alamar was then added to each well and the plates were incubated for another 2 hours. The plates were then read with a Spectramax Gemini XS microplate fluorometer (Molecular Devices Cooperation).
The IC50 values were calculated as in 2.2.
Results and discussion
The inhibitory concentration (IC50) and selectivity index (SI) values of plant extracts that demonstrated significant antiplasmodial activity (IC50 ≤ 5 μg/ml) when tested against the chloroquine sensitive strain of P. falciparum (NF54) are shown in Table 1 . Selectivity index (SI) values were calculated by dividing the IC50 value for the cytotoxicity by the IC50 value of antiplasmodial activity. It is generally considered that the antimalarial efficacy of a given plant extract is not due to the in vitro cytotoxicity when the SI ≥ 10, therefore displaying selective antiplasmodial activity (Vonthron-Senecheau et al., 2003) . For the purpose of this study, a plant extract was considered to be a potential hit for drug discovery when the IC50 was ≤ 5 μg/ml and an SI value of ≥ 10 could be established. Of all the 43 extracts assayed, 23%
exhibited pronounced selective antiplasmodial activity.
Tabernaemontana elegans was the best candidate, as both the dichloromethane and polar extracts from its stem bark inhibited plasmodial growth at IC50 = 0.33 and IC50 = 0.83 μg/ml, respectively. With respective SI values of 14 and 46, these extracts were considered to be non-toxic to rat skeletal myoblast L6 cells. Despite the wide ethnomedical use of T. elegans as an antimalarial remedy (Bandeira et al., 2001) , this is the first study to document its significant antiplasmodial activity. Studies conducted by Ramalhete et al., 2008 revealed moderate or no significant activity of polar leaf extracts from the same plant species. Nevertheless, studies conducted on indole alkaloids from a closely related species, T. sessilifolia, showed some good antiplasmodial activity (Girardot et al., 2012) , which could explain the observed bioactivity.
Dichloromethane root extract of Vangueria infausta subsp. infausta showed a marked inhibitory effect (IC50 = 1.84 μg/ml, SI = 25) against P. falciparum. A study conducted on chloroform root bark extract from V. infausta subsp. infausta significantly inhibited two strains of P. falciparum at IC50 of 3.80 and 4.50 μg/ml (Abosi et al., 2006) . Further studies are needed to determine the compounds responsible for the observed antiplasmodial activity. Chloroquine-sensitive strain of Although Albizia species are well documented for their strong in vitro as well as in vivo antimalarial activities (Samoylenko et al., 2009) , reports on A. versicolor are lacking. Clarkson et al. (2004) detected a weak antiplasmodial activity (IC50 = 38 μg/ml) in the dichloromethane root extract C. tomentosa, which is relatively low compared to the results (IC50 = 2.19 μg/ml) found in this study. An ethanol leaf extract from D. cinerea showed no activity at the highest concentration (5 μg/ml) tested (Atindehou, 2004) . Results from the current study do not support the relatively low antiplasmodial activity (IC50 ≥ 10 μg/ml) reported previously for R. caffra (Clarkson et al., 2004) . Boyom et al. (2011) reported on the potency of methanol leaf and stem extracts of X. parviflora from Cameroon. In agreement with the results obtained in this study, these extracts showed high in vitro antiplasmodial activity (IC50 ≤ 5 μg/ml).
The non-polar root extracts of Bridelia mollis and Cussonia spicata demonstrated significant in vitro antiplasmodial activity (IC50 ~3 μg/ml) and selectivity for malaria parasite with SI values of 17 and 15, respectively. In South Africa, B.
mollis is traditionally used as an antiparasitic against worms, among other uses, while a closely related species, B. micrantha is used against malaria-related fevers (Watt and Breyer-Brandwijk, 1962; Mabogo, 1990) . Literature data on the biological activity and phytochemical constituents of B. mollis is limited. The genus Cussonia has been extensively studied for its antiplasmodial properties, and the polar bark extracts of C. spicata were reported to have a relatively weak activity (De Villiers et al., 2010) . Results obtained in this study are consistent with those reported for other members of the same family, when extracted with non-polar solvent (Clarkson et al., 2004) . Although most of the investigated plant species have been previously tested against P. falciparum, data on the compounds attributable to their respective antiplasmodial activity is very limited.
It is worth noting that antimalarial activity was mainly found in lipophilic plant extracts, which confirm earlier reports that dichloromethane extracts generally have a higher antiplasmodial activity than methanol and aqueous extracts (Irungu et al., 2007) . Several species that were strongly associated with the treatment of malaria by Venda people and which are cited in ethnobotanical literature demonstrated weak antimalarial activity in this study. Thus, traditional remedies that are inactive against the Plasmodium asexual erythrocytic stage may be active against the hepatocyte phase, thereby preventing infection of red blood cells (Mesia et al., 2010) .
Investigations into treatments for malaria should therefore be directed at targeting the various stages of Plasmodium life-cycle and other clinical symptoms related to the disease state (Rasoanaivo et al., 2011) .
Conclusions
The findings of this study give a measure of credibility to the ethnomedical use of the investigated plant species by Venda people and to the rationale of an ethnopharmacological approach when bioprospecting medicinal plants for antiplasmodial lead compounds. Further phytochemical analyses are currently underway in an attempt to fractionate, isolate and identify the active constituents in extracts that demonstrated significant bioactivity.
